Saudi licensee starts distributing Viraleze
TGA approval of Viraleze in Australia
AstraZeneca updates on two Azd0466 trials
FDA approval of NDA for Vivagel BV
Dep Gemcitabine enters phase 1/2 clinical trial
Starpharma disclose Faslodex as the drug they are working on in house
A new partner is disclosed
Merck initiates a Dep candidate into phase 1/2 ADC human trial
And Russian troops start to withdraw from Ukraine
Wishful thinking this coming week
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
-0.002(2.00%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $37.67K | 384.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 39723 | 3 |
View Market Depth
| Last trade - 12.35pm 03/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |